FR2262662A1 - - Google Patents

Info

Publication number
FR2262662A1
FR2262662A1 FR7406982A FR7406982A FR2262662A1 FR 2262662 A1 FR2262662 A1 FR 2262662A1 FR 7406982 A FR7406982 A FR 7406982A FR 7406982 A FR7406982 A FR 7406982A FR 2262662 A1 FR2262662 A1 FR 2262662A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7406982A
Other languages
French (fr)
Other versions
FR2262662B1 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7406982A priority Critical patent/FR2262662B1/fr
Priority to DE19752508831 priority patent/DE2508831A1/de
Priority to CH256675A priority patent/CH603658A5/xx
Publication of FR2262662A1 publication Critical patent/FR2262662A1/fr
Application granted granted Critical
Publication of FR2262662B1 publication Critical patent/FR2262662B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
FR7406982A 1974-03-01 1974-03-01 Expired FR2262662B1 (xx)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR7406982A FR2262662B1 (xx) 1974-03-01 1974-03-01
DE19752508831 DE2508831A1 (de) 1974-03-01 1975-02-28 Thiophan-derivate, verfahren zu ihrer herstellung und ihre verwendung
CH256675A CH603658A5 (xx) 1974-03-01 1975-02-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7406982A FR2262662B1 (xx) 1974-03-01 1974-03-01

Publications (2)

Publication Number Publication Date
FR2262662A1 true FR2262662A1 (xx) 1975-09-26
FR2262662B1 FR2262662B1 (xx) 1978-08-11

Family

ID=9135645

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7406982A Expired FR2262662B1 (xx) 1974-03-01 1974-03-01

Country Status (3)

Country Link
CH (1) CH603658A5 (xx)
DE (1) DE2508831A1 (xx)
FR (1) FR2262662B1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337345A (en) * 1977-08-05 1982-06-29 Hoffmann-La Roche Inc. Preparation of biotin via thieno [3,2c] isoxazoles
EP0022446A1 (de) * 1979-04-06 1981-01-21 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Biotinestern und von Biotin
JPS603387B2 (ja) * 1980-07-10 1985-01-28 住友化学工業株式会社 新規光学活性イミダゾリジン−２−オン誘導体およびその製法
US4496739A (en) * 1982-01-27 1985-01-29 Sumitomo Chemical Company, Limited Intermediates to optically active cis-1,3-dibenzyl-hexahydro-1H-furo[3,4-d]imidazole-2,4-dione
ZA966885B (en) * 1995-08-22 1998-02-16 Du Pont Merck Pharma Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors.

Also Published As

Publication number Publication date
CH603658A5 (xx) 1978-08-31
DE2508831A1 (de) 1975-09-18
FR2262662B1 (xx) 1978-08-11

Similar Documents

Publication Publication Date Title
FR2296313B1 (xx)
FR2262662B1 (xx)
JPS50124312A (xx)
AU495844B2 (xx)
AR199089A1 (xx)
AU7474374A (xx)
JPS50109460A (xx)
JPS50139178A (xx)
JPS50100650A (xx)
BG21661A1 (xx)
BG22667A1 (xx)
BG20186A1 (xx)
CH583607A5 (xx)
BG20662A1 (xx)
CH583746A5 (xx)
CH607479A5 (xx)
BG20665A1 (xx)
BG19607A1 (xx)
BG20670A1 (xx)
CH583032A5 (xx)
BG20724A1 (xx)
BG20849A1 (xx)
CH573721A5 (xx)
BG21791A1 (xx)
AU479987A (xx)

Legal Events

Date Code Title Description
ST Notification of lapse